Trial Profile
An Open-Label Drug Interaction Study to Assess the Effect of Multiple-Dose Administration of JNJ-42847922 on the Single-Dose Pharmacokinetics of Midazolam and the Single Dose Pharmacokinetics and Pharmacodynamics of Warfarin in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Seltorexant (Primary) ; Midazolam; Warfarin
- Indications Insomnia; Major depressive disorder
- Focus Pharmacodynamics; Pharmacokinetics
- Sponsors Janssen Research & Development
- 22 Feb 2016 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Dec 2015 New trial record